Aptevo Therapeutics Inc
Biotechnology
Healthcare
APVO
10.55 M shares
NASDAQ US
traded
07 Apr 2025
listed
no
open
1.32
52 week high
31.38
high
1.62
52 week low
1.38
previous Close
1.49
P/E ratio
market cap
2.21 M
div yield
0
net incoming
-5.10 M
13.29 %
net profit margin
-510100000.00 %
0.00 %
operating incoming
-5.21 M
13.46 %
net change in cash
-313.00 K
85.67 %
cash on hand
7.75 M
-3.88 %
top